Disease/Infection News

RSS

HIV/AIDS status grim in Australia: Experts

Reports show that most Australians are complacent about getting AIDS. They feel that unless a person is homosexual or an injecting drug user or a sex worker, they are not at risk.

19 Oct 2010

ACG 75th Scientific Meeting to review advances in gastrointestinal research, treatment of digestive diseases

Many of the world's preeminent gastroenterologists will gather for the American College of Gastroenterology's (ACG) 75th Annual Scientific Meeting at the Henry B. Gonzalez Convention Center in San Antonio, Texas starting Monday October 18, 2010, to review the latest scientific advances in gastrointestinal research, treatment of digestive diseases and clinical practice management.

19 Oct 2010

Cytheris initiates ORVACS Phase II clinical trial to study HIV infection

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of Phase II clinical trial of the company's investigative immunomodulatory agent, CYT107 (rhIL-7), in combination with two potent antiretroviral drugs represented by the integrase inhibitor raltegravir (ISENTRESS- Merck & Co.) and the CCR5 inhibitor, maraviroc (SELZENTRY- ViiV Healthcare).

19 Oct 2010

ADHA and GSK emphasize importance of proper brushing as key to maintaining oral health

With the theme "Healthy Habits are Easier than You Think" for its National Dental Hygiene Month (NDHM) celebration this October, the American Dental Hygienists' Association (ADHA), in collaboration with GlaxoSmithKline (GSK), makers of Aquafresh®, emphasizes the importance of proper brushing as a key to maintaining excellent oral health.

19 Oct 2010

Government Officials, U.N. Staff meet with sex workers in Asia to examine access to HIV services

In parts of Asia, policies outlawing sex work are undermining HIV/AIDS prevention efforts by fragmenting and stigmatizing the sex workers and turning condom possession into an act that could lead to jail time, NGO officials say, IRIN reports.

19 Oct 2010

New research coalition to design first human trial of mosaic HIV vaccine candidate

Duke University Medical Center vaccine experts have assembled an international team of investigators to design and implement the first human trial of a mosaic HIV vaccine candidate, a novel strategy that attempts to counter one of the most daunting challenges in HIV vaccine design: the virus's extensive genetic diversity

19 Oct 2010

Researchers explore impact of various factors on increasing rates of Clostridium difficile infection

In five different studies presented at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, researchers explored the impact of various factors on increasing rates of Clostridium difficile infection (C. difficile), such as the use of proton pump inhibitors (PPIs) and the substantial increase in antibiotic use due to new National Hospital Quality Measures; strategies to combat high rates of C. difficile infections; and cutting‐edge treatments for this potentially deadly-and quite common-infection.

19 Oct 2010

Dengue cases in Western Pacific doubled in last 10 years; WHO says disease needs higher profile

The number of dengue cases has more than doubled in the last decade in the Western Pacific, according to the WHO, BBC reports.

19 Oct 2010

Micronics to advance PanNAT system for molecular diagnosis of infectious pathogens

Micronics, Inc., a development-stage company, today announced that the Department of Defense has awarded the company an Applied Research and Technology Development Award under the U.S. Army Medical Research and Materiel Command's Polytrauma and Blast Injury project for advancement of its PanNAT system for point-of-care molecular diagnosis of infectious pathogens.

19 Oct 2010

Scientists complete genetic blueprints for 13 different strains of Lyme disease bacteria

Scientists supported by the National Institutes of Health (NIH) have determined the complete genetic blueprints for 13 different strains of Borrelia burgdorferi, the bacteria that cause Lyme disease. The achievement should lead to a better understanding of how genetic variations among strains may result in different courses of illness in people with Lyme disease, the most common tickborne disease in North America. The wealth of new genetic data will also help scientists develop improved ways to diagnose, treat and prevent Lyme disease.

19 Oct 2010

Study finds IAP enzyme maintains normal microbial population in gastrointestinal system

An enzyme that keeps intestinal bacteria out of the bloodstream may also play an important role in maintaining the normal microbial population of the gastrointestinal system.

19 Oct 2010

NeurogesX plans U.S. label expansion for Qutenza in HIV-associated neuropathy

NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced plans to pursue a U.S. label expansion for Qutenza® (capsaicin) 8% patch to include patients with painful HIV-associated neuropathy (HIV-AN, also referred to as HIV-distal sensory polyneuropathy (HIV-DSP)).

19 Oct 2010

Egg allergy is no reason to avoid 2010-2011 flu vaccination

Having an egg allergy is not a reason to avoid getting the 2010-2011 flu vaccination.

19 Oct 2010

The state of sexually transmissible and blood-borne infections in Australia: the 2010 Surveillance Reports

Australia last year reported its largest number of new HIV cases since the early 1990s but has seen a reduction in cases of hepatitis, infectious syphilis and gonorrhoea, new data contained in HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2010 shows.

18 Oct 2010

The future face of HIV in Australia

The profile of people living with HIV in Australia is set to change significantly over the next decade. Among these changes are increases in new HIV infections; increases in the number of older men and women living with HIV; and a greater proportion of people with HIV living outside major metropolitan areas.

18 Oct 2010

BARACLUDE sNDA receives FDA approval for treatment of CHB patients with decompensated liver disease

Bristol-Myers Squibb Company announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) of BARACLUDE for the treatment of chronic hepatitis B (CHB) in adult patients with decompensated liver disease.

18 Oct 2010

Sequella to develop SQ109 further with EDCTP, LMU, and TB experts in PanACEA

Sequella, Inc., a clinical-stage company focused on commercializing novel drugs for treatment of life-threatening infectious diseases, announced it has signed an agreement with the Ludwig-Maximilians-University (LMU) of Munich to coordinate a European Union grant for Phase 2 clinical trials of SQ109 in adult pulmonary tuberculosis (TB) in seven sites in Africa.

18 Oct 2010

58% of scientists believe in surge of bedbug infestations: Survey

58% of scientists responding to a survey by Principal Investigators Association believe in a surge of bedbug infestations.

18 Oct 2010

GeoVax Labs contributes article for HIV vaccine

Robert T. McNally, Ph.D., president and CEO of GeoVax Labs, Inc. a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, has contributed an article on the search for an HIV vaccine to the October 15 issue of Genetic Engineering & Biotechnology News (GEN).

18 Oct 2010

HHS awards $4.8 million grant for Teen Prevention Education Program

The Princeton Center for Leadership Training (PCLT), in collaboration with long-time partner HiTOPS, was awarded a five-year, $4.8 million federal grant from the U.S. Department of Health and Human Services (HHS) to replicate and evaluate a teen sexual health peer education program, known as the Teen Prevention Education Program (Teen PEP), in 16 high schools in rural North Carolina communities with high teen birth rates.

18 Oct 2010

Disease/Infection News

HIV/AIDS status grim in Australia: Experts

ACG 75th Scientific Meeting to review advances in gastrointestinal research, treatment of digestive diseases

Cytheris initiates ORVACS Phase II clinical trial to study HIV infection

ADHA and GSK emphasize importance of proper brushing as key to maintaining oral health

Government Officials, U.N. Staff meet with sex workers in Asia to examine access to HIV services

New research coalition to design first human trial of mosaic HIV vaccine candidate

Researchers explore impact of various factors on increasing rates of Clostridium difficile infection

Dengue cases in Western Pacific doubled in last 10 years; WHO says disease needs higher profile

Micronics to advance PanNAT system for molecular diagnosis of infectious pathogens

Scientists complete genetic blueprints for 13 different strains of Lyme disease bacteria

Study finds IAP enzyme maintains normal microbial population in gastrointestinal system

NeurogesX plans U.S. label expansion for Qutenza in HIV-associated neuropathy

Egg allergy is no reason to avoid 2010-2011 flu vaccination

The state of sexually transmissible and blood-borne infections in Australia: the 2010 Surveillance Reports

The future face of HIV in Australia

BARACLUDE sNDA receives FDA approval for treatment of CHB patients with decompensated liver disease

Sequella to develop SQ109 further with EDCTP, LMU, and TB experts in PanACEA

58% of scientists believe in surge of bedbug infestations: Survey

GeoVax Labs contributes article for HIV vaccine

HHS awards $4.8 million grant for Teen Prevention Education Program

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News